Stable cyclosporine containing ophthalmic emulsion for treating dry eyes
Abstract
Disclosed herein are stable oil-in-water emulsion ophthalmic topical liquid compositions having an average particle size less than 1 μm including at least one plant-derived oil other than castor oil wherein the oil comprises only aliphatic side chains free of polar pendent groups. The oil-in-water emulsion ophthalmic topical liquid compositions also include a hydrophilic surfactant having an HLB value between approximately 10 and 14, a vegetable oil-derived hydrophobic non-co-block surfactant having unsaturated side chains that contain less than four oxygen atoms having an HLB value between approximately 4 and 6 and is a liquid at room temperature. The oil-in-water emulsion ophthalmic topical liquid compositions disclosed herein can further include an amount of cyclosporine A effective to relieve dry eye symptoms.
Claims
exact text as granted — not AI-modified1 . A stable oil-in-water emulsion ophthalmic topical liquid composition having an average particle size less than 1 μm comprising:
at least one plant-derived oil other than castor oil wherein said oil comprises only aliphatic side chains free of polar pendent groups; a hydrophilic surfactant having an HLB value between approximately 10 and 14; a vegetable oil-derived hydrophobic non-co-block surfactant having unsaturated side chains that contain less than four oxygen atoms, an HLB value between approximately 4 and 6 and is a liquid at room temperature; and wherein in said ophthalmic composition further comprises an amount of cyclosporine A effective to relieve dry eye symptoms.
2 . The ophthalmic composition according to claim 1 wherein the hydrophilic surfactant is Lumulse® GRH-25 and the hydrophobic surfactant is Brij 93.
3 . The ophthalmic composition according to claim 1 wherein the plant-derived non-polar oil is sesame oil.
4 . A stable oil-in-water emulsion ophthalmic topical liquid composition having an average particle size less than 0.6 μm consisting essentially of:
at least one plant-derived oil other than castor oil wherein said oil comprises aliphatic side chains free of polar pendent groups; a hydrophilic surfactant having an HLB value between approximately 10 and 11;
a vegetable oil-derived hydrophobic non-co-block surfactant having unsaturated side chains that contain less than four oxygen atoms, an HLB value between approximately 4 and 6 and is a liquid at room temperature; and
wherein in said ophthalmic composition further comprises an amount of cyclosporine A effective to relieve dry eye symptoms.
5 . The ophthalmic composition according to claim 4 wherein the hydrophilic surfactant is Lumulse® GRH-25 and the hydrophobic surfactant is Brij 93.
6 . The ophthalmic composition according to claim 4 wherein the plant-derived non-polar oil is sesame oil.
7 . A stable oil-in-water emulsion ophthalmic topical liquid composition having an average particle size less than 0.6 μm consisting essentially of sesame oil, a hydrophilic surfactant consisting of Lumulse® GRH-25, a hydrophobic non-co-block surfactant consisting of Brij 93 and wherein in said ophthalmic composition further comprises an amount of cyclosporine A effective to relieve dry eye symptoms.Join the waitlist — get patent alerts
Track US2010305046A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.